GlassScriptPhysician profile
Monica J Simons
NPI 1306922901
$1,723.95
in general payments reported to CMS, 2019-2025
22 companies · $88.64 in 2025
The $88.64 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $159 · 2021: $473 · 2022: $63.53 · 2023: $258 · 2024: $274 · 2025: $88.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $320.95 | 2023-2025 | Myfembree, Gemtesa |
| Merck Sharp & Dohme LLC | $197.44 | 2019-2025 | Keytruda, Lynparza, Gardasil 9 |
| Abbvie INC. | $192.93 | 2019-2021 | |
| Davol INC. | $167.94 | 2020-2021 | |
| Myovant Sciences INC. | $145.68 | 2021-2022 | |
| Therapeuticsmd, INC. | $139.71 | 2019-2021 | |
| Coopersurgical, INC. | $115.06 | 2019-2022 | |
| Organon LLC | $58.76 | 2023-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $48.41 | 2019-2021 | |
| Evofem Biosciences, INC. | $46.64 | 2021 | |
| Amgen INC. | $41.88 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.33 | 2019 | |
| Mayne Pharma Commercial LLC | $34.76 | 2021-2022 | |
| Astellas Pharma US INC | $26.77 | 2024 | Veozah |
| Shield Therapeutics INC | $21.22 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $21.17 | 2024 | |
| Mylan Pharmaceuticals INC. | $20.00 | 2019 | |
| Millicent US INC | $19.91 | 2025 | Intrarosa |
| Lupin INC. | $19.60 | 2019 | |
| Medtronic, INC. | $16.59 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $15.20 | 2019 | |
| Agile Therapeutics, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.